Skip to Content

Notice

National Center for Advancing Translational Sciences; Notice of Meetings

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Center for Advancing Translational Sciences Advisory Council.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Cures Acceleration Network Review Board.

Date: September 14, 2012.

Time: 8:30 a.m. to 2:30 p.m.

Agenda: Report from the Acting Institute Director.

Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892.

Contact Person: Jane A. Steinberg, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, Bethesda, MD 20892, 301-443-3367.

Name of Committee: National Center for Advancing Translational Sciences Advisory Council.

Date: September 14, 2012.

Open: 8:30 a.m. to 2:30 p.m.

Agenda: Report from the Acting Institute Director.

Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892.

Closed: 3:00 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892.

Contact Person: Jane A. Steinberg, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, Bethesda, MD 20892, 301-443-3367.

Dated: August 13, 2012

Jennifer Spaeth

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2012-20273 Filed 8-16-12; 8:45 am]

BILLING CODE 4140-01-P